Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC technology, a revolutionary new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays.
Clearmind Secures New Patent for Psychedelic Therapy
The TDR Three Key Takeaways for Clearmind: Clearmind Medicine’s innovative therapy gets patent approval in China. The company’s IP portfolio now includes 27 granted patents